Literature DB >> 27069016

Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition.

Rob R H van den Brom1, Wayel H Abdulahad2, Abraham Rutgers2, Bart-Jan Kroesen3, Caroline Roozendaal3, Derk Jan A de Groot1, Carolien P Schröder1, Geke A P Hospers1, Elisabeth Brouwer4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27069016     DOI： 10.1093/rheumatology/kew063

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  25 in total

Review 1.  Cardiovascular toxicities associated with immune checkpoint inhibitors.

Authors:  Jiun-Ruey Hu; Roberta Florido; Evan J Lipson; Jarushka Naidoo; Reza Ardehali; Carlo G Tocchetti; Alexander R Lyon; Robert F Padera; Douglas B Johnson; Javid Moslehi
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

Review 2.  Systemic Vasculitis Associated With Immune Check Point Inhibition: Analysis and Review.

Authors:  Teresa M Crout; Day S Lennep; Shweta Kishore; Vikas Majithia
Journal:  Curr Rheumatol Rep       Date:  2019-05-21       Impact factor: 4.592

3.  Vasculitis associated with immune checkpoint inhibitors-a systematic review.

Authors:  Anisha Daxini; Keri Cronin; Antoine G Sreih
Journal:  Clin Rheumatol       Date:  2018-06-19       Impact factor: 2.980

4.  Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer.

Authors:  Christopher S Nabel; Mariano Severgnini; Yin P Hung; Amy Cunningham-Bussel; Evisa Gjini; Katja Kleinsteuber; Lake J Seymour; Martha K Holland; Rachel Cunningham; Kristin D Felt; Marina Vivero; Scott J Rodig; Elena M Massarotti; Osama E Rahma; Lauren C Harshman
Journal:  Oncologist       Date:  2019-05-14

Review 5.  Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review.

Authors:  Meghan E Sise; Harish Seethapathy; Kerry L Reynolds
Journal:  Oncologist       Date:  2019-03-22

6.  Diminished PD-L1 regulation along with dysregulated T lymphocyte subsets and chemokine in ANCA-associated vasculitis.

Authors:  Jagdeep Singh; Ranjana Walker Minz; Biman Saikia; Ritambhra Nada; Aman Sharma; Saket Jha; Shashi Anand; Manish Rathi; Sanjay D'Cruz
Journal:  Clin Exp Med       Date:  2022-10-11       Impact factor: 5.057

7.  Pembrolizumab-associated nephrotic syndrome recovered from transient hemodialysis in a patient with lung cancer.

Authors:  Kento Ishibuchi; Takamasa Iwakura; Mai Kaneko; Hirotaka Fukasawa; Ryuichi Furuya
Journal:  CEN Case Rep       Date:  2020-03-13

8.  The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors.

Authors:  Harish Seethapathy; Sophia Zhao; Donald F Chute; Leyre Zubiri; Yaa Oppong; Ian Strohbehn; Frank B Cortazar; David E Leaf; Meghan J Mooradian; Alexandra-Chloé Villani; Ryan J Sullivan; Kerry Reynolds; Meghan E Sise
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-31       Impact factor: 8.237

9.  CMTM6-Deficient Monocytes in ANCA-Associated Vasculitis Fail to Present the Immune Checkpoint PD-L1.

Authors:  Markus Zeisbrich; Nina Chevalier; Bettina Sehnert; Marta Rizzi; Nils Venhoff; Jens Thiel; Reinhard E Voll
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

10.  Incidence and Prediction of Immune Checkpoint Inhibitor-related Nephrotoxicity.

Authors:  Jonathan D Sorah; Tracy L Rose; Roshni Radhakrishna; Vimal K Derebail; Matthew I Milowsky
Journal:  J Immunother       Date:  2021-04-01       Impact factor: 4.912
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.